N/A
NPS Score
VS
MyoKardia Claimed Company
- EMPLOYEE
PARTICIPANTS - 2
- TOTAL
RATINGS
Supernus Pharmaceuticals Claimed Company
- EMPLOYEE
PARTICIPANTS - 13
- TOTAL
RATINGS
MyoKardia vs Supernus Pharmaceuticals
Competitors at MyoKardia is not yet available. Get insights into the competitive rankings of MyoKardia CEO Rating, Culture Score, Brand Ranking, and other rankings soon.
MyoKardia
MyoKardia's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of MyoKardia. Their current market cap is $11.99B.
Supernus Pharmaceuticals
Supernus Pharmaceuticals's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of Supernus Pharmaceuticals. Their current market cap is $1.56B.
4/5
Product Quality
4.2/5
4/5
Pricing
3.9/5
4/5
Customer Service
4.2/5
| 0% | Promoters |
|---|---|
| 0% | Passive |
| 0% | Detractors |
50
NPS Score
| 75% | Promoters |
|---|---|
| 0% | Passive |
| 25% | Detractors |
Net Promoter Score
Winner by 50
See how MyoKardia compares to its competitors
See how Supernus Pharmaceuticals compares to its competitors
Working at MyoKardia vs Working at Supernus Pharmaceuticals
Not enough ratings
CEO Rating
70 / 100
CEO Rating
Winner
MyoKardia
MyoKardia doesn't have enough ratings to calculate the Team Culture Ratings.
Know someone that works there? Invite them to rate their experience.
Supernus Pharmaceuticals
Employees at Supernus Pharmaceuticals rate their CEO, Jack Khattar, 70/100.